
Health Technology Holding (HTH)
Italy
HTH is an investment and advisory firm investing in health-focused innovators since 2016. They work closely with pharma companies to fund life science ventures, provide corporate innovation capabilities, and open stakeholder networks. Their science-first approach involves deep due diligence, including data, models, and clinical expert interviews, typically completed within 1-2 months.
Fund scope
Investment criteria breakdown.
Investment stages
Pre-Seed
Seed
Series A
Series B+
Target regions
USA
Canada
Europe
Israel
Investment ranges
$500K - $1M
Focus areas
Biotech
Deeptech
Health
Partners
Fund leadership and team.
Related Sector Funds
Funds investing in similar industries.